Spyre Therapeutics Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
30.33
|
|
Average Rating
|
5.00
|
|
# Strong Buys
|
10
|
|
# Buys
|
0
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2024-09-30
|
-0.82
|
-1.36
|
-0.54
|
-65.85%
|
|
2024-06-30
|
-0.95
|
-0.86
|
0.09
|
9.47%
|
|
2024-03-31
|
-1.17
|
-1.20
|
-0.03
|
-2.56%
|
|
2023-12-31
|
-0.78
|
-4.05
|
-3.27
|
-419.23%
|
|
2023-09-30
|
-0.84
|
-9.34
|
-8.50
|
-1011.90%
|
|
2023-06-30
|
-3.48
|
-56.25
|
-52.77
|
-1516.38%
|
|
2023-03-31
|
-0.18
|
-4.55
|
-4.37
|
-2427.78%
|
|
2022-12-31
|
-0.23
|
-5.00
|
-4.77
|
-2090.10%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2024-09-30
|
-3.42
|
|
2023-12-31
|
-74.19
|
|
2022-12-31
|
-25.33
|
|
2021-12-31
|
-25.00
|
|
2020-12-31
|
-40.25
|
|
2019-12-31
|
-61.25
|
|
2018-12-31
|
-52.75
|
|
2017-12-31
|
-11.17
|
|
2016-12-31
|
-178.91
|